Jonathan Clark Neal
Directeur/Membre du Conseil chez Shire Pharmaceutical Contracts Ltd.
Profil
Jonathan Clark Neal currently works at Shire Pharmaceutical Contracts Ltd., as Director from 2019, Shire Pharmaceuticals Ltd., as Director from 2019, Auralis Ltd., as Director from 2019, and Baxalta UK Ltd., as Director from 2019.
Postes actifs de Jonathan Clark Neal
| Sociétés | Poste | Début |
|---|---|---|
Shire Pharmaceutical Contracts Ltd.
 Shire Pharmaceutical Contracts Ltd. Pharmaceuticals: MajorHealth Technology Shire Pharmaceutical Contracts Ltd. develops medicines for patients with rare diseases. The company was incorporated on June 2, 1986 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | 12/03/2019 |
Shire Pharmaceuticals Ltd.
 Shire Pharmaceuticals Ltd. BiotechnologyHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals Ltd. is a patient-focused, British innovation-driven pharmaceutical company. The company is based in London, UK. Takeda has a distinguished 240-year history and aspires to bring better health and a brighter future for people worldwide. Shire Pharmaceuticals was founded in 1986. The CEO is Flemming Ørnskov. | Directeur/Membre du Conseil | 12/03/2019 |
Baxalta UK Ltd.
 Baxalta UK Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2014, Baxalta UK Ltd. is a subsidiary of Takeda Pharmaceutical Co., Ltd. that manufactures biopharmaceutical products. The company is based in London, UK. | Directeur/Membre du Conseil | 12/03/2019 |
Auralis Ltd.
 Auralis Ltd. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Auralis Ltd. is a British company that develops and manufactures pharmaceutical products. The company is based in London, UK. The company was founded in 2005 by Simon Peter Bryson. Auralis was acquired by Shire ViroPharma, Inc., part of Takeda Pharmaceutical Co., Ltd. from January 27, 2014 on May 28, 2010 for $28.95 million. | Directeur/Membre du Conseil | 12/03/2019 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Auralis Ltd.
Auralis Ltd. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Auralis Ltd. is a British company that develops and manufactures pharmaceutical products. The company is based in London, UK. The company was founded in 2005 by Simon Peter Bryson. Auralis was acquired by Shire ViroPharma, Inc., part of Takeda Pharmaceutical Co., Ltd. from January 27, 2014 on May 28, 2010 for $28.95 million. | Health Technology |
Baxalta UK Ltd.
Baxalta UK Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2014, Baxalta UK Ltd. is a subsidiary of Takeda Pharmaceutical Co., Ltd. that manufactures biopharmaceutical products. The company is based in London, UK. | Health Technology |
Shire Pharmaceutical Contracts Ltd.
Shire Pharmaceutical Contracts Ltd. Pharmaceuticals: MajorHealth Technology Shire Pharmaceutical Contracts Ltd. develops medicines for patients with rare diseases. The company was incorporated on June 2, 1986 and is headquartered in London, the United Kingdom. | Health Technology |
Shire Pharmaceuticals Ltd.
Shire Pharmaceuticals Ltd. BiotechnologyHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals Ltd. is a patient-focused, British innovation-driven pharmaceutical company. The company is based in London, UK. Takeda has a distinguished 240-year history and aspires to bring better health and a brighter future for people worldwide. Shire Pharmaceuticals was founded in 1986. The CEO is Flemming Ørnskov. | Health Technology |
